Opinion: Our ESG Act protects investors, limits your financial risks from left-wing activism
1792_admin
Originally published July 25, 2023
Latest Content
Carbon Measures: Measuring the Wrong Bottom Line
September 30, 2026Carbon Measures represents a global coalition of businesses establishing a carbon emissions framework for company value chains which, ultimately, informs and restructures a business’s policies regarding emissions. The carbon accounting “framework” is no more than an extension of ESG integration into business practices, which puts business missional priority on the back burner while putting strain on suppliers. The coalition ultimately aims to influence policy: product-level carbon intensity standards that would “create markets in which businesses are rewarded for investing in low-carbon production.” That should concern businesses. Businesses are limited on resources: time and attention being absolute essentials for any business. When carbon becomes the primary measure, the business’ central mission automatically takes a back seat. Companies no longer fight for the quality of product that customers seek. When a customer comes to a business to purchase a product, they receive an abstract ideology purchased alongside a worthless product. Competition now lies in the order of the regulator. Specifically, to this coalition, “innovation, competition, and the power of the market” are vague empty platitudes, lacking in any specific details, for any sensible businessman to know that businesses are not built on whims or maybes.
The Companies That Left HRC’s Index Are Still Sponsoring Gender Ideology
September 29, 2026Several major corporations that publicly stepped back from DEI programs and the Human Rights Campaign’s Corporate Equality Index may not have retreated as far as headlines suggested. A new Blaze Media report, drawing on 1792 Exchange’s tracking, finds that Ford, Molson Coors, Target, and T-Mobile continued to bankroll LGBT activist events in 2026 even after signaling reform. The piece uses 1792 Exchange’s work on corporate DEI commitments, CEI participation, and ideological nonbusiness activities to show the gap between what these companies announced and what they still fund. Each of the four had signaled a change: Ford (2024) and Molson Coors (2024) said they would exit the CEI, and Target (2025) and T-Mobile (2025) announced they were ending DEI initiatives and index participation. Yet in 2026, Target was listed as a platinum sponsor of NYC Pride — whose youth programming included a rally “to demand protections for trans and queer youth” — along with Pride events in Los Angeles, Houston, San Francisco, Salt Lake City, and New Jersey. Molson Coors, through its Vizzy brand, sponsored Pride events in Miami Beach, Denver, and New Jersey; T-Mobile backed Pride events in Phoenix, Des Moines, and Philadelphia. Children appear to have been present at …
Inspire Investing Maps the Four-Year Reversal on Gender-Transition Care for Minors
September 22, 2026On August 11, 2026, the Centers for Medicare & Medicaid Services issued a first-of-its-kind final rule barring federal Medicaid and CHIP dollars from covering puberty blockers, cross-sex hormones, or surgeries for minors, effective October 13, 2026. A new analysis from Inspire Investing frames the rule as the capstone of a four-year reversal across American law, medicine, and corporate benefit plans. The piece, by Chris Hubbard with Tim Schwarzenberger, traces how a once-expanding consensus fractured, in the courts, in the medical literature, in Europe, and in corporate boardrooms, and why values-driven investors are now pressing companies on the issue. The Supreme Court’s June 2025 ruling in United States v. Skrmetti upheld state limits, leaving bans in roughly 27 states in force. A May 2025 HHS evidence review found the certainty of benefit “very low,” echoing England’s Cass Review. Corporate participation in the Human Rights Campaign’s Corporate Equality Index fell 65% in a single year, from 377 Fortune 500 companies to 131. 1792 Exchange has named 550-plus companies whose plans still cover these procedures for minor dependents and wrote to 568 companies in June urging them to exclude transgender drugs and surgeries for children. Inspire organized a coalition representing more than $100 …
Berkeley Study Finds No Financial Upside to Maintaining DEI
September 21, 2026A new Berkeley study, Markets Do Not Punish Firms for Maintaining DEI, examines whether S&P 500 companies that maintained diversity, equity, and inclusion programs after the Trump administration’s January 2025 DEI executive order suffered financially compared with companies that rolled them back. The authors conclude that companies maintaining DEI performed “just as well” in stock-market returns and revenue, arguing that businesses can resist federal pressure on DEI without suffering significant financial consequences. But the inverse is equally important for corporate leaders: companies that rolled back DEI also performed just as well. The study found no statistically significant stock-market or revenue advantage from maintaining DEI across its various measures of corporate commitment. That finding is notable given longstanding claims that DEI improves financial performance. If particular DEI practices create shareholder value, companies should be able to identify which DEI practices increase shareholder value and at what point benefits begin to diminish. The study also captures only part of the risk environment. Its revenue analysis extends through July 2025, before several major federal enforcement actions involving allegedly discriminatory employment practices. IBM, Deloitte, and Accenture have since agreed to settlements totaling more than $63 million, while Nike has faced separate EEOC scrutiny. The Berkeley …
Mount Sinai Backs Down. Will Corporate America?
September 21, 2026The writing is on the wall for gender ideology and corporate America should respond. Its authorities are discredited, its sciences unfounded, and its public support dwindling — not to mention the very providers who push sex-denying procedures on minors are now being held accountable for the experiment they’ve been running. Mount Sinai Health System is the latest example of this as they reach an agreement with the Department of Justice to stop providing sex-denying procedures on minors and provide free health care to those experiencing adverse side-effects of their experimentation. DOJ began its investigation on the premise that the nonprofit hospital may have violated federal law regarding its sex-denying procedures on children. The nationwide probe follows the landmark HHS report that exposed WPATH perverse influences on providers, along with an insurance scheme that let hospitals to charge insurance, private and federally subsidized, for sex-denying procedures on minors that would typically not be covered. Additionally, Mount Sinai agreed to dedicate $2 million to treating the adverse effects of sex-denying interventions, free of charge, to those who received them as minors. Keep in mind, sex-denying interventions are largely irreversible and carry side effects into adulthood, even for those who detransition. Detranstitioner Chloe …